Sharon Kunder

Sharon Kunder is an experienced professional in pharmacovigilance and patient safety, currently serving as Executive Director at Dragonfly Therapeutics, Inc. since May 2024, following a tenure as Sr. Director at Kiniksa Pharmaceuticals from September 2020 to April 2024. Sharon has held various leadership roles in global medical safety at Kiniksa and previously at Takeda, Shire, and Infinity Pharmaceuticals. Additionally, Sharon has a background in clinical research, having worked as an Adjunct Faculty member at Boston College. Sharon holds a Master of Science in Biomedical Engineering from Louisiana Tech University and a CRA/CRC Certificate from Boston College, alongside a Bachelor of Engineering in Biomedical Engineering from D.J Sanghavi College of Engineering.